Marketing-authorisation holder · United States
Adhera
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| PRESTALIA10mg base; 14mg | 2.5mg base; 3.5mg | 5mg base; 7mg · Tablet | Amlodipine, Perindopril | United States | Not marketed | 2015 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
U.S. Food and Drug Administration (Drugs@FDA, openFDA)
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Headquarters
- United States
- Medicines
- 1
- Countries
- 1
- Roles
- Authorisation holder